Awareness of a patient’s potential procedures and changes in nutritional intake enables the pharmacist to prevent hypoglycemic events by proactively adjusting the insulin regimen.
This agent recently achieved an additional indication to reduce myocardial infarction, stroke, coronary revascularization, and cardiovascular death risk in adult patients with ASCVD.
Addressing this autoimmune disorder characterized by thrombosis or pregnancy morbidity coupled with persistent antiphospholipid antibodies involves identifying and mitigating thrombosis risk factors.